Search Results - "Dharnidharka, V R"

Associations Between EBV Serostatus and Organ Transplant Type in PTLD Risk: An Analysis of the SRTR National Registry Data in the United States by Dharnidharka, V. R., Lamb, K. E., Gregg, J. A., Meier‐Kriesche, H.‐U.

“…In a prior multiorgan transplant database study, recipient Epstein–Barr virus (EBV) seronegativity was not associated with increased risk for posttransplant…”
Get full text

Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA) by Orandi, A B, Baszis, K W, Dharnidharka, V R, Huber, A M, Hoeltzel, M F

“…There is no standardized approach to the management of JDM-associated calcinosis and its phenotypes. Current knowledge of treatment outcomes is confined to…”
Get full text

Dissociation of Depletional Induction and Posttransplant Lymphoproliferative Disease in Kidney Recipients Treated With Alemtuzumab by Kirk, A. D., Cherikh, W. S., Ring, M., Burke, G., Kaufman, D., Knechtle, S. J., Potdar, S., Shapiro, R., Dharnidharka, V. R., Kauffman, H. M.

“…Transplant patients are at the risk for posttransplant lymphoproliferative disease (PTLD), a virally‐driven malignancy. Induction with the depleting antibody…”
Get full text

Prescription opioid use before and after kidney transplant: Implications for posttransplant outcomes by Lentine, K. L., Lam, N. N., Naik, A. S., Axelrod, D. A., Zhang, Z., Dharnidharka, V. R., Hess, G. P., Segev, D. L., Ouseph, R., Randall, H., Alhamad, T., Devraj, R., Gadi, R., Kasiske, B. L., Brennan, D. C., Schnitzler, M. A.

“…Evolving literature suggests that the epidemic of prescription opioid use affects the transplant population. We examined a novel database wherein national U.S…”
Get full text

Retransplantation After BK Virus Nephropathy in Prior Kidney Transplant: An OPTN Database Analysis by Dharnidharka, V. R., Cherikh, W. S., Neff, R., Cheng, Y., Abbott, K. C.

“…BK virus (BKV) has emerged as a major complication of kidney transplantation. Since June 30, 2004, the OPTN in the USA collects BKV as a primary or secondary…”
Get full text

Improved Survival with Recent Post‐Transplant Lymphoproliferative Disorder (PTLD) in Children with Kidney Transplants by Dharnidharka, V. R., Martz, K. L., Stablein, D. M., Benfield, M. R.

“…Post‐transplant lymphoproliferative disorder (PTLD) has been associated with high mortality, but recent anecdotal survival appeared better. From 1988 to 2010,…”
Get full text

Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data by Vest, L. S., Koraishy, F. M., Zhang, Z., Lam, N. N., Schnitzler, M. A., Dharnidharka, V. R., Axelrod, D., Naik, A. S., Alhamad, T. A., Kasiske, B. L., Hess, G. P., Lentine, K. L.

“…While guidelines support metformin as a therapeutic option for diabetic patients with mild‐to‐moderate renal insufficiency, the frequency and outcomes of…”
Get full text

Posttransplantation Lymphoproliferative Disorder in Kidney and Heart Transplant Recipients Receiving Thymoglobulin: A Systematic Review by Marks, W.H, Ilsley, J.N, Dharnidharka, V.R

“…Abstract Posttransplantation lymphoproliferative disorder (PTLD) is an important complication of transplantation. Risk factors include increased overall…”
Get full text

Peripheral Blood Epstein–Barr Viral Nucleic Acid Surveillance as a Marker for Posttransplant Cancer Risk by Dharnidharka, V. R.

“…Several viruses, such as Epstein–Barr virus, are now known to be associated with several human cancers, but not all patients with these viral infections…”
Get full text

Younger Age and Antibody Induction Increase the Risk for Infection in Pediatric Renal Transplantation: A NAPRTCS Report by Puliyanda, D. P., Stablein, D. M., Dharnidharka, V. R.

“…Infections now exceed rejection as a cause of hospitalization in the first 2 years post‐renal transplantation. We analyzed data from the North American…”
Get full text

Risk Factors for Hospitalization for Bacterial or Viral Infection in Renal Transplant Recipients—An Analysis of USRDS Data by Dharnidharka, V. R., Agodoa, L. Y., Abbott, K. C.

“…We previously showed that children are more likely to develop viral infections post‐kidney transplant while adults are more likely to develop bacterial…”
Get full text

Infected kidney cysts by Dharnidharka, V.R.

Get full text

The impact of direct‐acting antiviral agents on liver and kidney transplant costs and outcomes by Axelrod, D. A., Schnitzler, M. A., Alhamad, T., Gordon, F., Bloom, R. D., Hess, G. P., Xiao, H., Nazzal, M., Segev, D. L., Dharnidharka, V. R., Naik, A. S., Lam, N. N., Ouseph, R., Kasiske, B. L., Durand, C. M., Lentine, K. L.

“…Direct‐acting antiviral medications (DAAs) have revolutionized care for hepatitis C positive (HCV+) liver (LT) and kidney (KT) transplant recipients…”
Get full text

The Changing Financial Landscape of Renal Transplant Practice: A National Cohort Analysis by Axelrod, D. A., Schnitzler, M. A., Xiao, H., Naik, A. S., Segev, D. L., Dharnidharka, V. R., Brennan, D. C., Lentine, K. L.

“…Kidney transplantation has become more resource intensive as recipient complexity has increased and average donor quality has diminished over time. A national…”
Get full text

Adolescent Transition to Adult Care in Solid Organ Transplantation: A consensus conference report by Bell, L. E., Bartosh, S. M., Davis, C. L., Dobbels, F., Al‐Uzri, A., Lotstein, D., Reiss, J., Dharnidharka, V. R.

“…Transition of care from pediatric to adult‐oriented health care providers is difficult for children with special health care needs. Children who have received…”
Get full text

National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence‐Based Regimen Selection by Axelrod, D. A., Naik, A. S., Schnitzler, M. A., Segev, D. L., Dharnidharka, V. R., Brennan, D. C., Bae, S., Chen, J., Massie, A., Lentine, K. L.

“…Immunosuppression management in kidney transplantation has evolved to include an increasingly diverse choice of medications. Although informed by patient and…”
Get full text

Systemic Epstein-Barr virus infection associated with membranous nephropathy in children by Araya, C E, González-Peralta, R P, Skoda-Smith, S, Dharnidharka, V R

“…Epstein-Barr virus (EBV) infection can cause diverse renal manifestations ranging from microscopic hematuria to acute renal failure. Membranous nephropathy…”
Get more information

Economic Impacts of ABO‐Incompatible Live Donor Kidney Transplantation: A National Study of Medicare‐Insured Recipients by Axelrod, D., Segev, D. L., Xiao, H., Schnitzler, M. A., Brennan, D. C., Dharnidharka, V. R., Orandi, B. J., Naik, A. S., Randall, H., Tuttle‐Newhall, J. E., Lentine, K. L.

“…The infrequent use of ABO‐incompatible (ABOi) kidney transplantation in the United States may reflect concern about the costs of necessary preconditioning and…”
Get full text

The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection by BRISCOE, D. M, DHARNIDHARKA, V. R, ISAACS, C, DOWNING, G, PROSKY, S, SHAW, P, PARENTEAU, N. L, HARDIN-YOUNG, J

“…Engineered tissues have been proposed for the treatment of a variety of conditions including the partial or complete replacement of human organs. To determine…”
Get full text

Prevalence of microalbuminuria in children with sickle cell disease by DHARNIDHARKA, V. R, DABBAGH, S, ATIYEH, B, SIMPSON, P, SARNAIK, S

“…Renal involvement is common in homozygous sickle cell disease (HbSS), including glomerular hypertension and hypertrophy similar to that seen in rodent models…”
Get full text